Lundberg Sven Ante has filed 52 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 20363 shares of Q32 Bio Inc. ($QTTB) on January 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 20363 | $2.75 | 20,363.0000 | 12,304,352 | 9999.99% | 0.17% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | D | Share Option (right to buy) | 295000 | $0.00 | 0.0000 | 75,844,579 | 100.00% | 0.39% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | D | Share Option (right to buy) | 380000 | $0.00 | 0.0000 | 75,844,579 | 100.00% | 0.50% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | D | Share Option (right to buy) | 360000 | $0.00 | 0.0000 | 75,844,579 | 100.00% | 0.47% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | D | Share Option (right to buy) | 300000 | $0.00 | 0.0000 | 75,844,579 | 100.00% | 0.40% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | D | Share Option (right to buy) | 351628 | $0.00 | 0.0000 | 75,844,579 | 100.00% | 0.46% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | D | Share Option (right to buy) | 312620 | $0.00 | 0.0000 | 75,844,579 | 100.00% | 0.41% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | U | Common Shares | 9192 | $97.00 | 0.0000 | 75,844,579 | 100.00% | 0.01% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | U | Common Shares | 9192 | $97.00 | 0.0000 | 75,844,579 | 100.00% | 0.01% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | U | Common Shares | 9191 | $97.00 | 0.0000 | 75,844,579 | 100.00% | 0.01% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | U | Common Shares | 9191 | $97.00 | 0.0000 | 75,844,579 | 100.00% | 0.01% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | U | Common Shares | 30297 | $97.00 | 0.0000 | 75,844,579 | 100.00% | 0.04% |
| Dec. 12, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | U | Common Shares | 16372 | $97.00 | 0.0000 | 75,844,579 | 100.00% | 0.02% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 30297 | $0.00 | 83,435.0000 | 75,844,579 | 57.02% | 0.04% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 2539 | $0.00 | 83,435.0000 | 75,844,579 | 3.14% | 0.00% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 2539 | $0.00 | 83,435.0000 | 75,844,579 | 3.14% | 0.00% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 2539 | $0.00 | 83,435.0000 | 75,844,579 | 3.14% | 0.00% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 2538 | $0.00 | 83,435.0000 | 75,844,579 | 3.14% | 0.00% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 24229 | $0.00 | 83,435.0000 | 75,844,579 | 22.50% | 0.03% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 22449 | $0.00 | 83,435.0000 | 75,844,579 | 21.20% | 0.03% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 52369 | $0.00 | 83,435.0000 | 75,844,579 | 38.56% | 0.07% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 12215 | $0.00 | 83,435.0000 | 75,844,579 | 12.77% | 0.02% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 14198 | $0.00 | 83,435.0000 | 75,844,579 | 14.54% | 0.02% |
| Nov. 25, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 30297 | $0.00 | 83,435.0000 | 75,844,579 | 26.64% | 0.04% |
| Oct. 23, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| May 22, 2025 | Vor Biopharma Inc. | $VOR | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 124,851,547 | 9999.99% | 0.02% |
| April 17, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | M | Common Shares | 3797 | $12.54 | 3,797.0000 | 69,090,469 | 9999.99% | 0.01% |
| April 17, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | M | Share Option (right to buy) | 3797 | $12.54 | 0.0000 | 69,090,469 | 100.00% | 0.01% |
| April 17, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | M | Common Shares | 26500 | $13.52 | 30,297.0000 | 69,090,469 | 697.92% | 0.04% |
| April 17, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | M | Share Option (right to buy) | 26500 | $13.52 | 312,620.0000 | 69,090,469 | 7.81% | 0.04% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 23140 | $0.00 | 23,140.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 23140 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 15, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 23140 | $0.00 | 23,140.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 1316 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 2880 | $0.00 | 2,880.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 2880 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 6238 | $0.00 | 6,238.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 6238 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 2013 | $0.00 | 2,013.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 2013 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 19, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 40601 | $0.00 | 40,601.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | G | Common Shares | 40601 | $0.00 | 40,601.0000 | 0 | 50.00% | 0.00% |
| Feb. 13, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | M | Common Shares | 16372 | $24.43 | 40,601.0000 | 0 | 67.57% | 0.00% |
| Feb. 13, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | M | Share Option (right to buy) | 16372 | $0.00 | 351,628.0000 | 0 | 4.45% | 0.00% |
| Jan. 29, 2025 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | A | Share Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 25, 2024 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 1316 | $0.00 | 1,316.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | Vor Biopharma Inc. | $VOR | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| May 7, 2024 | Merus N.V. | $MRUS | Lundberg Sven Ante | President, CEO & PEO | A | Share Option (right to buy) | 360000 | $0.00 | 360,000.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Q32 Bio Inc. | $QTTB | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Vor Biopharma Inc. | $VOR | Lundberg Sven Ante | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |